News

Lenacapavir offers twice-yearly HIV prevention with near-complete protection in clinical trials. Clinical trials show ...
The Food and Drug Administration (FDA) recently approved lenacapavir for HIV prevention in both men and women. Many experts believe this twice a year treatment could be a game changer in the fight … ...
MELODY CHIRONDA | The Joint United Nations Programme on HIV/AIDS (UNAIDS) has warned that the global AIDS response is in ...
Prosper Okonkwo is the founding CEO of APIN-Public Health Initiatives, a leading Nigerian NGO that emerged from Harvard T.H.
This groundbreaking HIV initiative designed to meet Black and LGBTQ+ communities where they are — spiritually, culturally, ...
Until recently, the UN was on track to meet its target of ending AIDS as a public health threat by 2030. But with the U.S.
Congress just passed a sweeping bill that includes changes to Medicaid expected to cut millions of people with low incomes ...
The Joint United Nations Programme on HIV/AIDS (UNAIDS) warns that the global AIDS response is in crisis after a major ...
In the brightly lit corridors of a Nigerian hospital, an unspoken fear lingers, not just among patients, but among the very ...
How will the Trump administration's cuts to HIV research impact the progress that's been made towards ending the epidemic in ...